---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004210"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T06:13:02.609702+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs enters $7.73M equity line with Keystone Capital; issues 352,176 commitment shares

## Summary
- Up to $7,730,973 of common stock may be sold to Keystone Capital at 90% of lowest traded price or VWAP.
- Commitment fee: 352,176 shares issued to investor as consideration for the purchase commitment.
- Use of proceeds: working capital and general corporate purposes; 30% to redeem preferred stock if issued.
- Each fixed purchase limited to lower of 100,000 shares or $100,000; VWAP purchases capped at $5M aggregate.
- Investor prohibited from short sales or hedging during term; company retains termination right upon one day notice.

## SEC filing metadata
- accession: 0001493152-25-004210
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315225004210/0001493152-25-004210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315225004210/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004210
- JSON: https://secwatch.observer/filing/0001493152-25-004210.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004210.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.